Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples

Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples

Elena S Kotova,1 Yulia A Savochkina,2 Yuriy V Doludin,3 Alexander O Vasilyev,4 Elena A Prilepskay,4 Natalia V Potoldykova,3 Konstantin A Babalyan,1 Alexandra V Kanygina,1 Andrey O Morozov,3 Alexander V Govorov,4 Dmitry V Enikeev,3 Elena S Kostryukova,1 Elena N Ilina,1 Vadim M Govorun,1 Dmitry Y Push...

Full description

Bibliographic Details
Main Authors: Kotova ES, Savochkina YA, Doludin YV, Vasilyev AO, Prilepskay EA, Potoldykova NV, Babalyan KA, Kanygina AV, Morozov AO, Govorov AV, Enikeev DV, Kostryukova ES, Ilina EN, Govorun VM, Pushkar DY, Sharova EI
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Research and Reports in Urology
Subjects:
prostatic neoplasms
early diagnosis
neoplasm grading
alpha-methylacyl-coa racemase
rna.
Online Access:https://www.dovepress.com/identification-of-clinically-significant-prostate-cancer-by-combined-p-peer-reviewed-article-RRU

Internet

https://www.dovepress.com/identification-of-clinically-significant-prostate-cancer-by-combined-p-peer-reviewed-article-RRU

Similar Items